| Product Code: ETC12736206 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India nervous system therapeutics market import shipments experienced a notable decline with a CAGR from 2020 to 2024. However, there was a remarkable resurgence between 2023 and 2024, indicating a sudden spike in growth. Overall, the market exhibited fluctuations but ended with a significant positive trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Nervous System Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Nervous System Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Nervous System Therapeutics Market - Industry Life Cycle |
3.4 India Nervous System Therapeutics Market - Porter's Five Forces |
3.5 India Nervous System Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India Nervous System Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 India Nervous System Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Nervous System Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Nervous System Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in India |
4.2.2 Growing awareness about mental health and neurological disorders |
4.2.3 Advancements in medical technology and treatment options in nervous system therapeutics |
4.3 Market Restraints |
4.3.1 High cost of nervous system therapeutics medications |
4.3.2 Limited access to specialized healthcare services in remote areas of India |
4.3.3 Stringent regulatory requirements for drug approvals in the Indian market |
5 India Nervous System Therapeutics Market Trends |
6 India Nervous System Therapeutics Market, By Types |
6.1 India Nervous System Therapeutics Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India Nervous System Therapeutics Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 India Nervous System Therapeutics Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.1.4 India Nervous System Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.1.5 India Nervous System Therapeutics Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.6 India Nervous System Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2 India Nervous System Therapeutics Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Nervous System Therapeutics Market Revenues & Volume, By Antidepressants, 2021 - 2031F |
6.2.3 India Nervous System Therapeutics Market Revenues & Volume, By Antipsychotics, 2021 - 2031F |
6.2.4 India Nervous System Therapeutics Market Revenues & Volume, By CNS Stimulants, 2021 - 2031F |
6.2.5 India Nervous System Therapeutics Market Revenues & Volume, By Mood Stabilizers, 2021 - 2031F |
6.3 India Nervous System Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Nervous System Therapeutics Market Revenues & Volume, By Alzheimer's Disease, 2021 - 2031F |
6.3.3 India Nervous System Therapeutics Market Revenues & Volume, By Parkinson's Disease, 2021 - 2031F |
6.3.4 India Nervous System Therapeutics Market Revenues & Volume, By Multiple Sclerosis, 2021 - 2031F |
6.3.5 India Nervous System Therapeutics Market Revenues & Volume, By Epilepsy, 2021 - 2031F |
6.4 India Nervous System Therapeutics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Nervous System Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Nervous System Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 India Nervous System Therapeutics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031F |
6.4.5 India Nervous System Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
7 India Nervous System Therapeutics Market Import-Export Trade Statistics |
7.1 India Nervous System Therapeutics Market Export to Major Countries |
7.2 India Nervous System Therapeutics Market Imports from Major Countries |
8 India Nervous System Therapeutics Market Key Performance Indicators |
8.1 Number of neurologists and healthcare professionals specializing in nervous system therapeutics in India |
8.2 Adoption rate of innovative nervous system therapeutics treatments in the Indian market |
8.3 Investment in research and development of new nervous system therapeutics in India |
9 India Nervous System Therapeutics Market - Opportunity Assessment |
9.1 India Nervous System Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India Nervous System Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 India Nervous System Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Nervous System Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Nervous System Therapeutics Market - Competitive Landscape |
10.1 India Nervous System Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Nervous System Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here